Skip to content
  • News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Renal Cancer

  • Revlimid® Has Activity in Metastatic Renal Cell Carcinoma
    June 1, 2018

    Revlimid® Has Activity in Metastatic Renal Cell Carcinoma

    Dr. C H Weaver MD
  • Protein Linked with Kidney Cancer Prognosis
    June 1, 2018

    Protein Linked with Kidney Cancer Prognosis

    Dr. C H Weaver MD
  • Addition of Gliadel® Wafer to Surgery & Radiation Effective for Brain Metastasis
    June 1, 2018

    Addition of Gliadel® Wafer to Surgery & Radiation Effective for Brain Metastasis

    Dr. C H Weaver MD
  • Update on the Management of Genitourinary Malignancies
    June 1, 2018

    Update on the Management of Genitourinary Malignancies

    Dr. C H Weaver MD
  • Urologic and Colorectal Cancer Rates Linked in New Study
    June 1, 2018

    Urologic and Colorectal Cancer Rates Linked in New Study

    Dr. C H Weaver MD
  • Katherine Phillion: Kidney Cancer Survivor
    June 1, 2018

    Katherine Phillion: Kidney Cancer Survivor

    Dr. C H Weaver MD
  • Thalidomide and IL-2 Effective for Metastatic Renal Cell Carcinoma
    May 9, 2018

    Thalidomide and IL-2 Effective for Metastatic Renal Cell Carcinoma

    Dr. C H Weaver MD
  • Antibody C225 has Clinical Activity in Patients with Renal Cell Cancer
    May 4, 2018

    Antibody C225 has Clinical Activity in Patients with Renal Cell Cancer

    Dr. C H Weaver MD
  • Clinical Study Evaluating Dalantercept in Combination with Axitinib
    May 1, 2018

    Clinical Study Evaluating Dalantercept in Combination with Axitinib

    Dr. C H Weaver MD
  • Partial Nephrectomy for Renal Cell Cancer Can Achieve Long-Term Tumor Control
    January 1, 2018

    Partial Nephrectomy for Renal Cell Cancer Can Achieve Long-Term Tumor Control

    Dr. C H Weaver MD
  • Nexavar® Approved for Treatment of Advanced Kidney Cancer
    December 1, 2017

    Nexavar® Approved for Treatment of Advanced Kidney Cancer

    Dr. C H Weaver MD
  • Study Suggest Benefit of Nexavar® in the Treatment of Advanced Kidney Cancer
    December 1, 2017

    Study Suggest Benefit of Nexavar® in the Treatment of Advanced Kidney Cancer

    Dr. C H Weaver MD
Previous Page
1 … 8 9 10 11
Next Page
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy

Loading Comments...